Expert Questionnaire Survey and Result Analysis of TCM Symptom Assessment in High Risk Population of Osteoporosis in Ling-nan Region
1. Guangdong Provincial Hospital of Chinese Medicine/the Second Affiliated Hospital, Guangzhou University of Chinese Medicine, Guangzhou 510120, China 2. Bone and Joint Research Team of Degeneration and Injury, Guangdong Provincial Academy of Chinese Medical Sciences, Guangzhou 510120, China 3. The Second Clinical Medical College of Guangzhou University of Chinese Medicine/Post-doctoral Research Station, Guangzhou 510405, China 4. Guangdong Second Traditional Chinese Medicine Hospital/Guangdong Province Enginering Technology Research Institute of Traditional Chinese Medicine, Guangzhou 510095, China
ZENG Lingfeng,YANG Weiyi,LIANG Guihong, et al. Expert Questionnaire Survey and Result Analysis of TCM Symptom Assessment in High Risk Population of Osteoporosis in Ling-nan Region[J]. Chinese General Practice, 2023, 26(24): 2986-2991. DOI: 10.12114/j.issn.1007-9572.2022.0846.
曾令烽,杨伟毅,梁桂洪等. 骨质疏松高危人群中医症状评估专家问卷调查和结果研究[J]. 中国全科医学, 2023, 26(24): 2986-2991. DOI: 10.12114/j.issn.1007-9572.2022.0846.
TUCKS, LITTLEE A, ASPRAYT J. Implications of guidelines for osteoporosis and its treatment[J]. Age Ageing,2018,47(3):334-339. DOI:10.1093/ageing/afx197.
[4]
WANGL H, YUW, YINX J,et al. Prevalence of osteoporosis and fracture in China:the China osteoporosis prevalence study[J]. JAMA Netw Open,2021,4(8):e2121106. DOI:10.1001/jamanetworkopen.2021.21106.
BILBRON A, HIRSTA, PAEZA,et al. The IDEAL reporting guidelines:a Delphi consensus statement stage specific recommendations for reporting the evaluation of surgical innovation[J]. Ann Surg,2021,273(1):82-85. DOI:10.1097/SLA.0000000000004180.
[11]
FUNKE-CHAMBOURM, ALBERAC, BENDSTRUPE,et al. Suggestions for improving clinical utility of future guidelines for diagnosis and management of idiopathic pulmonary fibrosis:results of a Delphi survey[J]. Eur Respir J,2021,57(4):2004219. DOI:10.1183/13993003.04219-2020.
[12]
ZHAOJ L, XIAOX, ZHOUG H,et al. Effectiveness of Yushen Hezhi therapy for postmenopausal osteoporosis:an overview of systematic reviews of randomized controlled trials[J]. Front Endocrinol (Lausanne),2022,13:1015483. DOI:10.3389/fendo.2022.1015483.